The results of Akkari et al. (2020) [10] suggested that the TGF-β/Hippo and Notch signaling pathways were elevated in TAMs at recurrent glioma mice, including the gene NOTCH4. The gene discussed is TGFB1; the disease is central nervous system cancer.